These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2045598)

  • 1. UF researchers report new periodontal treatment.
    J Am Dent Assoc; 1991 May; 122(5):18. PubMed ID: 2045598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M; Ito T
    Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-lactamase inhibitors. I. In vivo evaluation of an amoxicillin + clavulanic acid combination in the treatment of urinary infections].
    Dalet F; Del Río G
    Rev Clin Esp; 1984 Feb; 172(3):153-7. PubMed ID: 6609385
    [No Abstract]   [Full Text] [Related]  

  • 4. Clavulanic acid inhibits beta-lactamases.
    FDA Drug Bull; 1984 Dec; 14(3):25. PubMed ID: 6335441
    [No Abstract]   [Full Text] [Related]  

  • 5. Use and abuse of antibiotics in periodontal therapy.
    Ciancio S
    Dent Econ; 1993 Jun; 83(6):98-100. PubMed ID: 8243788
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clavulanic acid-shielded amoxicillin in the treatment of acute and chronic infective diseases of the pulmonary system].
    Micillo E; Dericoloso A; Tranchese D; Cione P
    Arch Monaldi Mal Torace; 1987; 42(6):535-49. PubMed ID: 3334116
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of infective respiratory diseases with a shielded beta-lactam antibiotic (amoxicillin and clavulanic acid)].
    Palermo B; Rizza S; Pistorio MP; Crimi N; Maccarrone C; Mistretta A
    Arch Monaldi Mal Torace; 1987; 42(6):519-33. PubMed ID: 3334115
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
    White A; Cooper C; Stokes D
    Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-lactamase inhibitors].
    Gialdroni Grassi G
    G Ital Chemioter; 1982; 29(1):1-10. PubMed ID: 6764431
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial agents and periodontal disease.
    Goldberg MH
    J Am Dent Assoc; 1992 Feb; 123(2):14, 16. PubMed ID: 1541776
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new therapeutic strategy using a ofloxacin-amoxicillin-clavulanic acid combination in the treatment of upper gynecologic infections. Apropos of 123 cases].
    Verhoest P; Fernandez H; Henry-Suchet J; Orfila J; Boulanger JC
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(1):39-46. PubMed ID: 8157889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pediatric suspensions of amoxicillin and clavulanic acid in the treatment of bacterial infections of otorhinolaryngologic importance and the upper respiratory tract].
    Amendola F; Natuzzi M; De Mattia D; Schettini F
    Minerva Pediatr; 1989 Feb; 41(2):97-103. PubMed ID: 2786988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)].
    Migueres ML; Ronco E; Guenounou M; Philippon A
    Pathol Biol (Paris); 1989 May; 37(5):397-401. PubMed ID: 2674869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term experience with combined action of antibacterials.
    Jedlicková Z; Výmola F; Rubín A; Simková M
    Czech Med; 1986; 9(4):196-9. PubMed ID: 3102184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis.
    Penketh AR; Hodson ME; Batten JC
    Br J Clin Pract; 1984 May; 38(5):188-9. PubMed ID: 6610437
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination antibiotic for resistant bacterial strains.
    Pepper GA
    Nurse Pract; 1985 Mar; 10(3):49-50. PubMed ID: 3845395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of the efficacy of combined amoxicillin and clavulanic acid in acute odontostomatological pathology].
    Zoccola GC; Calogiuri PL; Ciotta D; Barbero P
    Minerva Stomatol; 1988 Dec; 37(12):1005-9. PubMed ID: 3241609
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of urinary infection with a combination of amoxycillin and clavulanic acid].
    Vránková J; Kocvara R
    Cas Lek Cesk; 1983 Sep; 122(37):1144-5. PubMed ID: 6627336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.